Phase 1 to Investigate Safety, Tolerability, PK/PK of J2H-1702 in Healthy Males
Status:
COMPLETED
Trial end date:
2021-07-13
Target enrollment:
Participant gender:
Summary
1. Research Purpose: To evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic properties of J2H-1702 (a candidate for treatment of non-alcoholic steatohepatitis) in healthy men.
2. Design: A dose block-randomized, double-blind, placebo controlled, single- and multiple dosing, dose-escalation phase 1 clinical trial